ID   BORRU
AC   CVCL_A1YK
DR   Wikidata; Q105506539
RX   PubMed=19276180;
RX   PubMed=22257080;
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 53.9 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=19276180; DOI=10.1158/1541-7786.MCR-08-0409;
RA   Ropolo M., Daga A., Griffero F., Foresta M., Casartelli G., Zunino A.,
RA   Poggi A., Cappelli E., Zona G., Spaziante R., Corte G., Frosina G.;
RT   "Comparative analysis of DNA repair in stem and nonstem glioma cell
RT   cultures.";
RL   Mol. Cancer Res. 7:383-392(2009).
//
RX   PubMed=22257080; DOI=10.1111/j.1750-3639.2012.00566.x;
RA   Raso A., Vecchio D., Cappelli E., Ropolo M., Poggi A., Nozza P.,
RA   Biassoni R., Mascelli S., Capra V., Kalfas F., Severi P., Frosina G.;
RT   "Characterization of glioma stem cells through multiple stem cell
RT   markers and their specific sensitization to double-strand
RT   break-inducing agents by pharmacological inhibition of ataxia
RT   telangiectasia mutated protein.";
RL   Brain Pathol. 22:677-688(2012).
//
RX   PubMed=24443327; DOI=10.1002/ijc.28680;
RA   Vecchio D., Daga A., Carra E., Marubbi D., Baio G., Neumaier C.E.,
RA   Vagge S., Corvo R., Brisigotti M.P., Ravetti J.L., Zunino A.,
RA   Poggi A., Mascelli S., Raso A., Frosina G.;
RT   "Predictability, efficacy and safety of radiosensitization of
RT   glioblastoma-initiating cells by the ATM inhibitor KU-60019.";
RL   Int. J. Cancer 135:479-491(2014).
//